Skip to content

Effectiveness of anma massage therapy for lymphedema in survivors of gynecologic cancer

Effectiveness of anma massage therapy for lymphedema in survivors of gynecologic cancer - Anma massage for lymphedema in survivors of gynecologic cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047815
Enrollment
1
Registered
2022-05-20
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphedema

Interventions

Anma massage therapy + usual care for lymphedema (wearing an elastic stocking): A 60-min whole-body anma massage session administered once a week for 6 weeks (6 sessions in total). Sessions are follow

Sponsors

MEXT(Japan)
Lead Sponsor
University of Tsukuba
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Diagnosis of gynecologic cancer and completion of standard medical treatment, with subsequent development of lymphedema

Exclusion criteria

Exclusion criteria: 1) Not completed standard medical treatment or currently undergoing chemotherapy or radiotherapy. 2) Inflammatory disorder of the lower limb, such as cellulitis, lymphangitis, and acute dermatitis 3) Deep vein thrombosis 4) Serious cardiac disease 5) Other disease that contraindicates anma massage therapy, such as severe dementia, severe kidney disease, and inflammatory disorder in other organs 6) Deemed ineligible to participate this study by a medical doctor (Research Collaborator)

Design outcomes

Primary

MeasureTime frame
Lower limb circumference (five circumference measurements: from the head of the first metatarsal to head of the fifth metatarsal; at the ankle, from the lateral to medial malleolus; 5 cm below head of the fibula; 10 cm above the top of the patella; and at the thigh, at the point of the greater trochanter) We measure before and after the intervention/control duration, and also measure before and after each session.

Secondary

MeasureTime frame
1) Quality of life, measured using a self-administered questionnaire, the Japanese version of Quality of Life Measurement for Limb Lymphedema (J-LYMQOL). 2) Blood flow velocity in the great saphenous vein, measured using a bidirectional vascular Doppler. We measure before and after the intervention/control duration.

Countries

Japan

Contacts

Public ContactNozomi DONOYAMA

Tsukuba University of Technology Department of Health, Faculty of Health Sciences

donoyama@k.tsukuba-tech.ac.jp+81-29-858-9631

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026